☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Myovant
Myovant and Pfizer Report Result of Relugolix Combination Therapy in P-III (SPIRIT 1 & 2) Studies for Endometriosis-Associated Pai...
June 20, 2022
PharmaShots Interview: Myovant's Dave Marek Shares Insights on the US FDA's Approval of Myfembree in Uterine Fibroids
July 20, 2021
PharmaShots Interview: Myovant's Juan Camilo Arjona Ferreira Shares Insights on the Ryeqo
July 5, 2021
PharmaShots Weekly Snapshots (May 24 - 28, 2021)
May 28, 2021
PharmaShots Weekly Snapshots (Feb 15- 19, 2021)
February 19, 2021
Top 20 Life Sciences Deals of 2020 by Total Deal Value
January 22, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.